Skip to main content
ConductScienceScienceDex

Courtney S Young

NIH Rank #5209
Unclaimed recordClaim profile
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 15029691Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$2.3M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#5,209
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Courtney S Young. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Courtney S Young as a PI. Multi-PI records show the full award amount for context.

  • 9R44NS141438-04R44
    Further assessment of durability of a gene editing therapy for Duchenne muscular dystrophy
    Myogene Bio, Llc
    $1.3M
    award amount
  • 1SB1AR084953-01A1SB1
    Advancing manufacturing and release testing of a gene editing therapy for Duchenne muscular dystrophy
    Myogene Bio, Llc
    $499.3K
    award amount
  • 1R21HD117763-01R21
    Assessment of restoration of an internally deleted dystrophin as a surrogate biomarker for future clinical trials of a gene editing therapy in Duchenne muscular dystrophy
    Myogene Bio, Llc
    $302.5K
    award amount
  • 5R21TR005162-02R21
    Durability of a gene editing therapy that restores dystrophin in a humanized mouse model of Duchenne muscular dystrophy
    Myogene Bio, Llc
    $201.3K
    award amount

Award organization

Organizations that administered FY2025 awards listing Courtney S Young as a PI.

FY2025 award administered by Myogene Bio, Llc (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Myogene Bio, Llc
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #5209

Explore further

Find collaborators for Courtney S Young

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →